162
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Bloodstream infection after living donor liver transplantation

, , , , , & show all
Pages 509-516 | Received 20 May 2007, Published online: 08 Jul 2009

References

  • Sugawara Y, Makuuchi M. Technical advancement in living-related liver transplantation. J Hep Bil Pancr Surg 1999; 16: 245–53
  • Singh N, Gayowski T, Wagener MM, Marino IR. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transpl 1997; 11: 275–81
  • Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology 1995; 21: 1328–36
  • Wagener MM, Yu VL. Bacteraemia in transplant recipients: a prospective study of demographics, aetiological agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239–47
  • Tucker ON, Heaton N. The ‘small-for-size’ liver syndrome. Curr Opin Crit Care 2005; 11: 150–5
  • Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67: 321–7
  • Liu CL, Fan ST, Lo CM, Wei WI, Chan SC, Yong BH, et al. Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole graft liver transplantation in a single centre. Ann Surg 2006; 243: 404–10
  • Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transpl 2005; 5: 1694–1703
  • Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant 2002; 16: 102–6
  • Demetrius AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658
  • Akamatsu N, Sugawara Y, Kaneko J, Kishi Y, Makuuchi M. Risk factors of cytomegalovirus infection after living donor liver transplantation. Hepatogastroenterology 2005; 52: 197–9
  • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183–97.
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128–40
  • Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definition of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606–8
  • Iinuma Y, Senda K, Fujihara N, Saito T, Takakura S, Kudo T, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004; 78: 704–9
  • Santoro-Lopes G, de Gouvea EF, Monterio RC, Branco RC, Rocco JR, Halpern M, et al. Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation. Liver Transpl 2005; 11: 203–9
  • Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteraemia in liver transplant recipients: shift toward Gram-negative bacteria as predominant pathogens. Liver Transpl 2004; 10: 844–9
  • Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review, a meta-analysis. Liver Transpl 2006; 12: 850–8
  • Singh N, Squier C, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients. Infect Control Hosp Epidemiol 2006; 27: 122–6
  • Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Predicting bacteraemia and bacteraemic mortality in liver transplant recipients. Liver Transpl 2000; 6: 54–61
  • Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988; 8: 385–401
  • ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and paediatric patients. JPEN J Parenter Enteral Nutr 2002; 26(Suppl 1)SA1–138
  • Santos JI. Nutrition, infection, and immunocompetence. Infect Dis Clin North Am 1994; 8: 243–67
  • Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996; 16: 389–402
  • Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906–12
  • McMahon MM, Bistrian BR. Host defences and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995; 9: 1–9
  • Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29–34
  • van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359–67
  • Pittet D, Li N, Wenzel RP. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 1993; 12: 813–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.